Comparing two scans to find neuroblastoma in children
Part of Cancer clinical trials.
This study compares two types of imaging scans to see which is better at finding neuroblastoma in children. Your child will get both a standard MIBG scan and a newer PET scan, and the results will be compared to help improve future detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed diagnosis of neuroblastoma (a type of cancer that starts in nerve cells).
- The cancer must have come back (relapsed) or not responded to treatment (refractory).
- A standard MIBG scan must show that the cancer takes up the tracer (called 'MIBG-avid').
- Your child must not receive any cancer treatment between the standard MIBG scan and the new PET scan (about 2 days apart).
- Your child must be at least 1 year old (365 days) and weigh at least 9 kg (about 20 pounds).
- Your child should be in reasonably good health, with a performance status of at least 60% on the Lansky or Karnofsky scale.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
This study is for children or young adults already in specific brain tumor or neuroblastoma trials. It looks at how a type of imaging (MCT) might help doctors better understand and treat these cancers.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.